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Background: Homoisoflavonoids are naturally occurring compounds belong to flavonoid classes possessing various
biological properties such as cytotoxicity. In this work, an efficient strategy for the synthesis of novel
homoisoflavonoids, [1,3]dioxolo[4,5-g]chromen-8-ones, was developed and all compounds were evaluated for their
cytotoxic activities on three breast cancer cell lines.
Methods: Our synthetic route started from benzo[d][1,3]dioxol-5-ol which was reacted with 3-bromopropanoic acid
followed by the reaction of oxalyl chloride to afford 6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one. The aldol
condensation of the later compound with aromatic aldehydes led to the formation of the title compounds. Five
novel derivatives 4a-e were tested for their cytotoxic activity against three human breast cancer cell lines including
MCF-7, T47D, and MDA-MB-231 using the MTT assay.
Results: Among the synthesized compounds, 7-benzylidene-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one (4a)
exhibited the highest activity against three cell lines. Also the analysis of acridine orange/ethidium bromide staining
results revealed that 7-benzylidene-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one (4a) and 7-(2-methoxybenzylidene)-
6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one (4b) induced apoptosis in T47D cell line.
Conclusion: Finally, the effect of methoxy group on the cytotoxicity of compounds 4b-4d was investigated in and
it was revealed that it did not improve the activity of [1,3]dioxolo[4,5-g]chromen-8-ones against MCF-7, T47D, and
MDA-MB-231.
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Homoisoflavonoids, naturally occurring compounds be-
long to flavonoid classes and possess a wide spectrum of
biological properties such as anti-inflammatory [1], anti-
oxidant [2], antiproliferative [3], antifungal [4], antiviral
[5], and antimutagenic activities [6]. They mainly in-
clude a chromanone, chromone, or chromane skeleton
and are ubiquitous in plants such as Ophiopogon [7], Poly-
gonatum [8], Scilla [9], Eucomis [10], and Muscari [11].
Recently, several homoisoflavonoids have been success-
fully isolated from plants and evaluated for their bioactiv-
ities [12,13].* Correspondence: aforoumadi@yahoo.com
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unless otherwise stated.Chalcones have been the center of attention owing to
their significant biological activities [14-18]. Also they are
the most important precursors for the formation of α,
β-unsaturated carbonyl system in flavonoid classes.
Homoisoflavonoids including chalcone system have
shown selective biological activities [19]. The isolated
natural homoisoflavonoids having 3-benzylidenechroman-
4-one skeleton were found to be potent and selective
MAO-B inhibitors. Compounds involving benzylidene
chromanone have depicted significant medicinal prop-
erties such as antioxidant [20], anticancer [21], anti-
inflammatory [22], anti-human-immune deficiency virus
(HIV-I) activities [23].
Two naturally occurring homoisoflavonoids, bonducellin
[24] 1 and eucomin [25] 2 (Figure 1), isolated from Caesal-
piniabonducella and Eucomis bicolor BAK (Liliaceae) wereLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Bonducellin 1 and Eucomin 2.
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logues have shown important biological properties such as
anti-tuberculosis activity [26] and inhibition of protein
tyrosine kinase (PTK) [27].
On the synthesis of bioactiveheterocycles containing oxy-
gen specially chalcones and homoisoflavonoids [9,21,28,29];
herein, we focused on new substituted [1,3]dioxolo[4,5-g]
chromen-8-one derivatives 4 to profit from both chalcones
and homoisoflavonoids (Scheme 1). Then, we evaluated
their cytotoxic activities against three human breast can-




All starting materials, reagents, and solvents were prepared
from Merck (Germany). Melting points were determined
on a Kofler hot stage apparatus (Vienna, Austria) and
are uncorrected. 1H-NMR spectra were recorded using a
Bruker 400 spectrometer (Bruker, Rheinstatten, Germany),
and chemical shifts are expressed as δ (ppm) with tetra-
methylsilane (TMS) as internal standard. The IR spectra
were obtained on a Nicolet Magna FT-IR 550 spectropho-
tometer (potassium bromide disks).
General procedure for the synthesis of [1,3]dioxolo[4,5-g]
chromen-8-one derivatives 4
3-(Benzo[d][1,3]dioxol-5-yloxy)propanoic acid 2 and 6,7-
dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one 3 pre-
pared according to [30] (Scheme 1).
Dry hydrogen chloride gas was passed through an ice-
cold solution of 6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chro-
men-8-one 3 (0.5 mmol) and benzaldehyde derivative
(0.7 mol) in absolute EtOH (3 mL) for 2 min. The reac-
tion mixture was allowed to stand at room temperature
for 48 h. The precipitated product was filtered off, dried,
and recrystallized from ethanol and water.Scheme 1 Synthesis of [1,3]dioxolo[4,5-g]chromen-8-ones 4. (a) NaOH
(c) aromatic aldehydes, HCl (g), 0°C.7-Benzylidene-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-
one (4a)
Yield: 48%, mp 141–144°C. IR (KBr): 1664 (C =O) cm−1.
1H-NMR (CDCl3, 400 MHz) δ: 7.83 (s, 1H, benzylidene),
7.43 (s, 1H, H9), 7.42-7.25 (m, 5H, Ph), 6.41 (s, 1H, H4),
6.00 (s, 2H, H1, CH2), 5.29 (s, 2H, CH2). Anal. Calcd. for
C17H12O4: C, 72.85; H, 4.32. Found: C, 72.68; H, 4.18.
7-(2-Methoxybenzylidene)-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]
chromen-8-one (4b)
Yield: 31%, mp 160–163°C. IR (KBr): 1660 (C =O) cm−1.
1H-NMR (CDCl3, 400 MHz) δ: 7.961 (s, 1H, benzylidene),
7.39 (s, 1H, H9), 7.04-6.94 (m, 4H, H3′, H4′, H5′, H6′), 6.40
(s, 1H, H4), 6.00 (s, 2H, H1, CH2), 5.17 (s, 2H, CH2), 3.86
(s, 3H, OCH3). Anal. Calcd. for C18H14O5: C, 69.67; H,
4.55. Found: C, 69.52; H, 4.41.
7-(3-Methoxybenzylidene)-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]
chromen-8-one (4c)
Yield: 42%, mp 161–163°C. IR (KBr): 1662 (C =O) cm−1.
1H-NMR (CDCl3, 400 MHz) δ: 7.79 (s, 1H, benzylidene),
7.38 (s, 1H, H9), 7.04-6.93 (m, 4H, H2′, H4′, H5′, H6′), 6.41
(s, 1H, H4), 6.00 (s, 2H, H1, CH2), 5.29 (s, 2H, CH2), 3.84
(s, 3H, OCH3). Anal. Calcd. for C18H14O5: C, 69.67; H,
4.55. Found: C, 69.83; H, 4.72.
7-(4-Methoxybenzylidene)-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]
chromen-8-one (4d)
Yield: 31%, mp 169–172°C. IR (KBr): 1665 (C =O) cm−1.
1H-NMR (CDCl3, 400 MHz) δ: 7.79 (s, 1H, benzylidene),
7.38 (s, 1H, H9), 7.26 (d, J = 8.4 Hz, 2H, H2΄, H6΄), 6.96
(d, J = 8.4 Hz, 2H, H3΄, H5΄), 6.42 (s, 1H, H4), 6.00 (s, 2H,
H1, CH2), 5.32 (s, 2H, CH2), 3.86 (s, 3H, OCH3). Anal.




Yield: 42%, mp 198–200°C. IR (KBr): 1667 (C =O) cm−1.
1H-NMR (CDCl3, 400 MHz) δ: 7.73 (s, 1H, benzylidene),
7.37 (s, 1H, H9), 6.86-6.67 (m, 3H, H3′, H4′, H6′), 6.41
(s, 1H, H4), 6.03 (s, 2H, H1′,CH2), 6.00 (s, 2H, H1, CH2),
5.29 (s, 2H, CH2). Anal. Calcd. for C18H12O6: C, 66.67;
H, 3.73. Found: C, 66.48; H, 3.55., Na2CO3, Br(CH2)2COOH, H2O, reflux, (b) oxalyl chloride, SnCl4, benzene,
Table 1 Chemical structures and in vitro cytotoxic activity
(IC50 , μg/ml)
a of compounds 4a-4e against breast cancer
cell lines
Entry Compound MCF-7 T47D MDA-MB-231
1 6.2 ± 0.1 4.6 ± 0.1 9.3 ± 2.1
2 > 100 5.7 ± 0.07 27.3 ± 7.1
3 > 100 18.8 ± 2.3 29.05 ± 1.7
4 > 100 9.2 ± 2.9 > 100
5 > 100 > 100 > 100
6 Doxorubicin 0.002 ± 0.002 0.03 ± 0.002 0.006 ± 0.004
7 Etoposide 7.5 ± 0.32 7.9 ± 0.45 11.9 ± 0.87
aThe IC50 values represent an average of three independent experiments
(mean ± SD).
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Cell lines and cell culture
Human breast cancer cell lines including MDA-MB231,
MCF-7 and T47D cells were obtained from the National
Cell Bank of Iran, Pasteur Institute, Tehran, Iran. Cancer
cell lines were grown in RPMI-1640 medium supple-
mented with 10% heat-inactivated fetal calf serum, 100 μg/
ml streptomycin and 100 U/ml penicillin at 37°C in a hu-
midified atmosphere with 5% CO2.
In vitro cytotoxicity assay
The in vitro cytotoxic activity of [1,3]dioxolo[4,5-g]chro-
men-8-ones 4a-e was achieved using MTT colorimetric
assay. The in-vitro cytotoxic activity of all synthesized
compounds were evaluated against three human breast
cancer cell lines including MCF-7, T47D and MDA-MB-
231 using MTTcolorimetric assay according to the method
of Mosman [31]. Cancer cell lines were grown in RPMI-
1640 medium supplemented with 10% heat-inactivated
fetal calf serum (Gibco BRL), 100 μg/ml streptomycin
and 100 U/ml penicillin at 37°C in a humidified atmos-
phere with 5% CO2.
Briefly, cultures in the exponential growth phase were
trypsinized and diluted in complete growth medium to
give a total cell count of 5 × 104 cells/ml. 195 μl of the
cell suspension was seeded into the wells of 96-well plates
(Nunc, Denmark). The plates were incubated overnight in
a humidified air atmosphere at 37°C with 5% CO2. After
overnight incubation, 5 μl of the media containing various
concentrations of the compounds was added per well in
triplicate (final concentration 1, 5, 10 and 20 μg/ml). The
plates were incubated for further 72 h. The final concen-
tration of DMSO in the highest concentration of the ap-
plied compounds was 0.1%. In each plate, there were three
control wells (cells without test compounds) and three
blank wells (the medium with 0.1% DMSO) for cell viabil-
ity. Etoposide and doxorubicine were used as positive con-
trols for cytotoxicity. After treatment, the medium was
removed and 200 μl phenol red-free medium containing
MTT (1 mg/ml), was added to wells, followed by 4 h incu-
bation. After incubation, the culture medium was then
replaced with 100 μl of DMSO and the absorbance of
each well was measured by using a microplate reader at
492 nm. For each compound, the concentration causing
50% cell growth inhibition (IC50) compared with the con-
trol was calculated from concentration response curves by
regression analysis.
Fluorescence microscopy evaluation
Acridine orange/ethidium bromide (AO/EB) double stain-
ing [32] was applied to observe the morphological changes
in cell death induced by the most potent compounds 4a
and 4b. Acridine orange is taken up by both viable and
dead cells and emitting green fluorescence if intercalatedinto double stranded nucleic acid (DNA) or red fluores-
cence if bound to single stranded nucleic acid (RNA) due
to its accumulation in lysosomes. Ethidium bromide is
taken up only by cells with an altered cell membrane and
emits red fluorescence by intercalation into DNA. Cells
were seeded in 6-well plates (4 × 105 cell/well) for 24 h.
Then, cells were treated with IC50 concentration of test
compounds for 24 h at 37°C with 5% CO2. After treat-
ment, cells were washed twice with phosphate buffer sa-
line (PBS) and then 1 μl of dye mixture (100 μg/ml
AO and 100 μg/ml EB in PBS were mixed with 25 μl
of cell suspension (0.4 × 106 cells/well) on a clean micro-
scope slide. The suspension was immediately examined by
Axoscope 2 plus fluorescence micro- scope from Zeiss
(Germany) at 40× magnification.
Results and discussions
Benzo[d][1,3]dioxol-5-ol 1 (Scheme 1) was converted to
3-(benzo[d][1,3]dioxol-5-yloxy)propanoic acid 2 and sub-
sequently to 6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-
8-one 3 according to the procedure [30]. In the next
step, we investigated the reaction of 6,7-dihydro-8H-[1,3]
dioxolo[4,5-g]chromen-8-one 3 and 4-methoxybenzaldehyde
to obtain the corresponding product, 7-(4-methoxybenzy-
lidene)-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one
(4d) (Table 1).
To run successful aldol condensation reaction, acid-
catalyzed and base-catalyzed approaches were investigated
using various conventional acids and base in different sol-
vents. It was found that the aldol condensation was con-
ducted in better yield in the presence of HCl (g).
Then, various derivatives including 7-(2-methoxybenzy-
lidene)-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one
(4b) and 7-(3-methoxybenzylidene)-6,7-dihydro-8H-[1,3]
dioxolo[4,5-g]chromen-8-one (4c) possessing methoxy
(OMe) group at ortho and meta positions were prepared
to compare their bioactivities against the studied cell
lines with that of the control. Also other two deriva-
tives, 7-benzylidene-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]
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ylmethylene)-6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-
8-one (4e) were prepared to investigate the effect of
methxoy substituent on the cytotoxicity (Table 1).
The in vitro cytotoxic activity of [1,3]dioxolo[4,5-g]
chromen-8-one derivatives 4, were tested against three
human breast cancer cell lines including MCF-7, T47D,
and MDA-MB-231. The 50% growth inhibitory concen-
tration (IC50) for all derivatives were calculated and
depicted in Table 1.
According to MTTassay results in Table 1, 7-benzylidene-
6,7-dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one (4a)
showed the highest activity against MCF-7, T47D, and
MDA-MB-231 cell lines with IC50 values of 6.2 ± 0.1,
4.6 ± 0.1, and 9.3 ± 2.1 μg/ml, respectively. In contrast,
7-(benzo[d][1,3]dioxol-5-ylmethylene)-6,7-dihydro-8H-
[1,3]dioxolo[4,5-g]chromen-8-one (4e) did not show
any cytotoxicity at the concentrations used. It seems
that the presence of benzo[d][1,3]dioxole in benzylidene
moiety decreases the cytotoxic activity of the correspond-
ing compound. As can be seen in Table 1 (Entries 2–4), by
introduction of OMe into the ortho, meta or para posi-
tions of benzylidenemoiety (compounds 4b, 4c, and 4d),
different results were observed. All of them were inactive
against MCF-7 cell line (IC50 > 100 μg/ml), whereas they
exhibited good activity against T47D cell line with IC50
values of 5.7 ± 0.07, 18.8 ± 2.3, and 9.2 ± 2.9 μg/ml,Figure 2 Morphological analysis of T47D cells treated with 4a and 4b
a) DMSO 1% as control, b) etoposide as positive control, c) cells treatedwit
live cells, dashed arrow shows apoptotic cells. The images of cells were takrespectively. It should be noted that compounds 4b and
4c were active against MDA-MB-231 cell line and 4d did
not show any activity in this cell line. Presence of OMe in
benzylidene moiety did not play crucial role on the im-
provement of cytotoxicity effects.
To study the effect of our synthetic compounds on cell
lines, acridine orange/ethidium bromide double staining
technique was used to evaluate the occurrence of apop-
tosis in cells. Analysis of the acridine orange/ethidium
bromide staining results showed that 7-benzylidene-6,7-
dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one (4a) and
7-(2-methoxybenzylidene)-6,7-dihydro-8H-[1,3]dioxolo
[4,5-g]chromen-8-one (4b) induced apoptosis in T47D cell
line (Figure 2). The cells treated with the most potent
compounds increased the extent of apoptosis relative to
untreated control cells. As shown in Figure 2, the non-
apoptotic control cells were stained green and the apop-
totic cells had orange particles in their nuclei due to
nuclear DNA fragmentation.
Conclusion
In conclusion, novel [1,3]dioxolo[4,5-g]chromen-8-one de-
rivatives were synthesized and tested for their cytotoxic
activity against three human breast cancer cell lines in-
cluding MCF-7, T47D, and MDA-MB-231 using the
MTT assay. 7-Benzylidene-6,7-dihydro-8H-[1,3]dioxolo
[4,5-g]chromen-8-one (4a) showed the highest activityby acridine orange/ethidium bromide double staining method.
h 4a for 24 h. d) cells treatedwith 4b for 24 h. White arrow indicates
en with a fluorescence microscope at 400 ×magnification.
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of acridine orange/ethidium bromide staining results
revealed that the cytotoxic effect of 7-benzylidene-6,7-
dihydro-8H-[1,3]dioxolo[4,5-g]chromen-8-one (4a) and
7-(2-methoxybenzylidene)-6,7-dihydro-8H-[1,3]dioxolo
[4,5-g]chromen-8-one (4b) may be due to inducing
apoptosis in cancer cell lines.
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